Non-invasive characteristics of atrial fibrillation: The value of Holter recordings for the treatment of AF

Cardiac Electrophysiology Review

Volumn 6, Issue 3, 2002, Pages 233-238

  Wijffels, Maurits C E F ^a   Crijns, Harry J G M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ablation; Atrium; Fibrillation; Flutter; Pulmonary veins

Indexed keywords

AMIODARONE; DISOPYRAMIDE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CASE REPORT; CATHETER ABLATION; COMORBIDITY; FEMALE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEREDITY; HOLTER MONITORING; HUMAN; INDIVIDUALIZATION; MALE; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; RECORDING; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 0036754134     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016324908012     Document Type: Article

References (42)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022.
2. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
3. Garrey WE. The nature of fibrillation contraction of the heart; its relation to tissue mass and form. Am J Physiol 1914;33:397-414.
4. Lewis T, Drury AN, Iliescu CC. A demonstration of circus movement in clinical fibrillation of the auricles. Heart 1921;8:361-379.
5. Engelmann TW. Über den einfluss der systole auf die motorische leitung in der herzkammer, mit bemerkungen zur theorie allorhythmischer herzstörungen. Arch Ges Physiol 1896;62:543.
6. Scherf D. Studies on auricular tachycardia caused by aconitine administration. Proc Soc Exp Biol Med 1947;64:233-239.
7. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
8. Allessie MA, Lammers WJEP, Bonke FIM, Hollen SJ. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J (eds). Cardiac Electrophysiology and Arrhythmias, Vol. 1, NY: Grune & Stratton, 1985: 265-275.
9. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
10. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: Structural, functional and electrophysiologic characteristics of a new model of sustained atrial fibrillation. Circulation 1995-91:1588-1595.
11. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-525.
12. Yu WC, Lee SH, Tai CT, Tsai CF, Hsieh MH, Chen CC, Ding YA, Chang MS, Chen SA. Reversal of electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999;42:470-476.
13. Mary-Rabine L, Albert A, Pham TD, Hordof AJ, Fenoglio JJ, Jr, Malm JR, Rosen MR. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res 1983;52:188-199.
14. Ausma J, Wijffels M, Thone F, Wouters L, Allessie MA, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
15. Wellens HJJ. Atrial fibrillation. The last big hurdle in treating supraventricular tachycardia. New Eng J Med 1994;331:944-945.
16. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG. Five year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993;56:814-823.
17. Maloney JD, Milner L, Barold S, Czerska B, Markel M. Two staged biatrial linear and focal ablation to restore sinus rhythm in patients with refractory chronic atrial fibrillation. Pacing Clin Electrophysiol 1998;21:2527-2532.
18. Wellens HJJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G, for the METRIX Investigators. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656.
19. Dijkman B, Wellens HJJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1196-1205.
20. Israel CW, Ehrlich JR, Grönefeld G, Klesius A, Lawo T, Lemke B, Hohnloser SH. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355-363.
21. Jaïs P, Haïssaguerre M, Shah D, Chouairi S, Gencel L, Hocini M, Clémenty J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
22. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: 659-666.
23. Huang DT, Monahan KM, Zimetbaum P, Papageorgiou P, Epstein LM, Josephson ME. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:462-469.
24. Nabar A, Rodriguez LM, Timmermans C, Smeets J, Wellens HJJ. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol 1999;83:785-787.
25. Suttorp MJ, Kingima HJ, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
26. Crijns HJGM, Wijk van LM, Gilst van WH, Kingma HJ, Van Gelder IC, Lie KI. Acute conversion of atrial fibrillation to sinus rhythm: Clinical efficacy of flecainide acetate. Comparison of two regimes. Eur Heart J 1988;9:634-638.
27. UK Propafenone PSVT Study Group. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 1995;92:2550-2557.
28. Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. Am J Cardiol 1996;77:53A-59A.
29. Brugada J, Gursoy S, Brugada P, Atie J, Guiraudon GM, Andries E. Cibenzoline transforms random reentry into ordered re-entry in the atria. Eur Heart J 1993;14:267-272.
30. Feld GK, Chen P, Nicod P, Fleck P, Meyer D. Possible atrial proarrhythmic effects of class IC antiarrhythmic drugs. Am J Cardiol 1990;66:378-383.
31. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qui A, Vorderbrugge S, Kerr CR. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 1990;66:755-757.
32. Ortiz J, Niwano S, Abe H, Rudy Y, Johnson NJ, Waldo AL. Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994;74:882-894.
33. Roithinger FX, Karch MR, Steiner PR, Sippens-Groenewegen A, Lesh MD. Relationship between atrial fibrillation and typical atrial flutter in humans: Activation sequence changes during spontaneous conversion. Circulation 1997;96: 3484-3491.
34. Stabile G, De Simone A, Turco P, La Rocca V, Nocerino P, Astarita C, Maresca F, De Matteis C, Di Napoli T, Stabile E, Vitale DF. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. J Am Coll Cardiol 2001;37:1639-1644.
35. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
36. Kirchhof CJHJ, Wijffels M, Brugada J, Planellas J, Allessie MA. Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol 1991;17:116-124.
37. Wang Z, Page PL, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
38. Wijffels MCEF, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat. Effects of cibenzoline, hydroquinidine, flecainide and d-sotalol. Circulation 2000;102:260-267.
39. Shah DC, Haïssaguerre M, Jaïs P, Mélèze H, Yamane T, Deisenhofer I, Garrigue S, Clémenty J. Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients: Strategy for presentation ranging from sustained atrial fibrillation to no arrhythmias. Pacing Clin Electrophysiol 1999;24:1541-1558.
40. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. Electrophysiological effects of radiofrequency ablation. Circulation 1999;100:1879-1886.
41. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-2628.
42. Gaita F, Riccardi R, Calo L, Scaglione M, Garberoglio L, Antolini R, Kirchner M, Lamberti F, Richiardi E. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation 1998;97:2136-2145.